Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 241 Carboplatin 166 Injections 138 Paclitaxel 118 Gemcitabine 116 Bevacizumab 113 Cisplatin 105 Docetaxel 80 Cyclophosphamide 77 Pemetrexed 76 Capecitabine 69 Fluorouracil 67 Oxaliplatin 65 Fulvestrant 58 Nivolumab 55 fludarabine 54 Cetuximab 52 Leucovorin 51 130-nm albumin-bound paclitaxel 48 Dexamethasone 46 Rituximab 41 atezolizumab 37 venetoclax 35 Drug Therapy 35 toripalimab 34 enzalutamide 34 Irinotecan 33 durvalumab 32 Prednisone 32 Letrozole 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDUSTRY × empagliflozin × Clear all

NCT03424005 2026-03-16

Morpheus-panBC

Hoffmann-La Roche

Phase 1/2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡